Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Online Exclusive | From the Member Sections | From the Sidelines to the Guidelines: A History of Palliative Care in the Heart Failure GuidelinesFor patients living with heart failure (HF), novel therapeutics have become guideline-directed care, transforming clinical practice and improving patients' lives. In parallel, cardiovascular clinicians increasingly recognize the value of palliative care (PC) for patients with serious cardiovascular illnesses...
- Eagle’s Eye View: SPECIAL AHA RECAP focusing on seven studies: ZEUS & Ziltivekima; HORIZON & Pelacarsen; OPTIMAL-STROKE & BP Control; STREAM & Statin Therapy; OPTIMA-DIABETES & BP Control Through Yoga, OptimPacing & Left Bundle-Branch Pacing; COAST-AF & Ablationn this special edition of the View, Dr. Eagle looks at seven studies presented at the recent American Heart Association Conference that could have immediate effects on your practice.
- Incorporating the Lipid and Cardiometabolic Clinic into Practice: Tips and TricksThis episode is part of ACC’s ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Explore key updates from the 2026 Guideline for the Treatment of Dyslipidemia with Drs. Eugenia Gianos and Michael Blaha, including connections to the 2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline.
- JACC LAAC Special Issue: ASAP-TOO Five-Year Results, LAAC Evidence Review, MoreA special issue of JACC published Thursday, Nov. 12, focuses on left atrial appendage closure (LAAC), presenting the most recent results from the ASAP-TOO trial, along with a JACC evidence review for LAAC vs. anticoagulation, and a number of analyses and viewpoints on current LAAC evidence, practice patterns and emerging clinical questions.
- CMS Finalizes Ambulatory Specialty Model For HF Beginning January 2027Despite multiple ACC requests for modifications or delay, the Centers for Medicare and Medicaid Services (CMS) declined to provide a transition or education period before implementation of the Ambulatory Specialty Model (ASM) for heart failure (HF). In the 2027 Medicare Physician Fee Schedule (PFS) final rule, released last week, CMS confirmed the model will begin […]



